Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.


2020 - Appointment as Consultant Ophthalmic Surgeon at the Oxford Eye Hospital

2019 - Leonhard Klein Award for the advancement of vitreoretinal surgery

2018 - Senator-Hermann-Wacker Award (German Ophthalmological Society)

2016 - Henning-Zügel Award for basic research in Ophthalmology

2015 - Appointment as Professor of Ophthalmology (Apl) at Eberhard Karls Universität Tübingen

2012 - Fellow European Board of Ophthalmology, FEBOphth

2012 - MRC Clinical Research Training Fellowship, UK Medical Research Council

2010 - Career Development Award, Karin and Ewald Hochbaum Foundation

2008 - NIH Young Investigator Award, NEI & Foundation Fighting Blindness

2001-07 - Academic Scholarship, Friedrich Naumann Foundation

2001-04 - Visiting Scholar at Dept. of Physiology, University of Pennsylvania

2001 - Henry R. Viet Fellow, Myasthenia Gravis Foundation of America

Subretinal gene therapy for RPE65-associated inherited retinal dystrophy. © Dominik Fischer
Subretinal gene therapy for RPE65-associated inherited retinal dystrophy.

M. Dominik Fischer

MD DPhil FEBOphth

Senior Clinical Fellow

  • Principal Investigator
  • Consultant Ophthalmic Surgeon

Research Summary

Professor Fischer is a Consultant Ophthalmic Surgeon specializing in retinal diseases and their treatment.

He became member of the medical faculty at the Eberhard Karl University Tübingen in 2012 and was appointed Professor of Ophthalmology at the Centre for Ophthalmology Tübingen in 2015, where he continues to lead a research lab and clinical trials. 

His academic work focuses on retinal gene therapy and translational research in retinal physiology and disease ( He leads the world's first post approval safety study for ocular gene therapy.

Professor Fischer has received more than 25 awards, among them the Leonhard Klein award for the advancement of vitreoretinal surgery and the Senator-Hermann-Wacker award for scientific contributions to the field of retinal and choroidal disease. He has given more than 100 invited lectures and is author of more than 70 peer reviewed articles.

He advises patient advocacy groups, biotech and pharmaceutical industry, has been expert advisor to the European Medicines Agency and acts as editor of several scientific journals.

Recent publications

More publications